1Curry SC,Chang D,Connor D. Drug and toxin-induced rhabdomyolysis. Annals of Emergency Medicine,1989,18:1068
2Gabow PA,Kaehny WD,Kelleher SP,.e spectrum of rhabdomylosis.Medicine, 1982,61:141
3Lane RJM,Mastsglia FL. Druginduced myopathies in man. Lancet,1978,2:562
4Pederson TR,Berg K,Cook TJ,et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian survival study. Archives of Internal Medicine, 1996,156:2085
5Tobert JA. Efficacy and long-term adverse effect pattern of lovastatin. American Journal of Cardiology, 1988,62: 28j
6Cheung AK,De Vault GA Jr,Gregory MC.A prospective study on the treatment of hypercholestrolemia with lovastatin in renal transplant recipients receiving cyclosporine. Journal of the American Society of Nephrology, 1993,3: 1884
7Terrovitou CT,Milonis HJ,Elisaf MS. Acute rhabdomyolysis after bezafibrate re - exposure. Nephron, 1998,78:336
8Wolfgang RK,Henning H. Rhabdomyolosis and Beta 2adrenoceptor agonists. Nephron, 1990,55:346
9Blake PG,Ryan F. Rhabdomyolosis and acute renal failure after terbutaline overdose . Nephron, 1989,53: 76
10Kendrick WC,Hull AR,Knocheel JP. Rhabdomyolosis and shock after intravenous amphetamine administration. Annal of Internal Medicine, 1977,6: 381
